Rosy S. Donn

Original Contribution

Preclinical Evaluation of Second-Generation Everolimus- and Zotarolimus-Eluting Coronary Stents

07/30/2013

Saami K. Yazdani , PhD;

Alexander Sheehy ;

Marc Vorpahl , MD;

Masataka Nakano , MD;

Fumiyuki Otsuka , MD, PhD;

Gaku Nakazawa , MD;

Charles A. Simonton III, MD;

Rosy S. Donn ;

Laura E. Perkins , DVM, PhD;

Renu Virmani , MD, PhD;

Frank D. Kolodgie , PhD;

Second-generation DES have alleviated the safety concerns of late stent thrombosis by addressing issues of polymer biocompatibility, stent design and optimizing drug loads and release kinetics. This study was designed to evaluate the...

Second-generation DES have...

07/30/2013

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

November 8

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

See Full Calendar

Rosy S. Donn

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products